Arcutis, Inc.’s ARQ-151 Development Program for Plaque Psoriasis
ARQ-151 Potential "Best in Class" Topical PDE4 inhibitor ARQ-151 Potentially Only Topical PDE4 inhibitor for Psoriasis Phase 2a Study in...
ARQ-151 Potential "Best in Class" Topical PDE4 inhibitor ARQ-151 Potentially Only Topical PDE4 inhibitor for Psoriasis Phase 2a Study in...
DENVER, CO / ACCESSWIRE / May 7, 2019 / International Cannabrands Inc. (CSE: JUJU) (the 'Company') is pleased to announce...
Appeals Court Set to Hear and Then Decide DECN's Seminal Legal Question at Issue in Long Simmering Patent Battle with...
CHARLOTTESVILLE, VA / ACCESSWIRE / May 7, 2019 / Adial Pharmaceuticals, Inc. (NASDAQ: ADIL; ADILW) www.adialpharma.com, a clinical-stage biopharmaceutical company...
SOUTH SAN FRANCISCO, CA / ACCESSWIRE / May 7, 2019 / VistaGen Therapeutics (NASDAQ: VTGN), a clinical-stage biopharmaceutical company developing...
HAMBURG, GERMANY / ACCESSWIRE / May 7, 2019 / Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809) will report...
WINNIPEG, MB / ACCESSWIRE / May 7, 2019 / Preferred Dental Technologies Inc. (PDTI) has been granted an additional patent...
Live Conference Call and Webcast Scheduled for May 14, 2019, at 9:00 a.m. ET ENGLEWOOD, CO / ACCESSWIRE / May...
TORONTO, ON / ACCESSWIRE / May 7, 2019 / Theralase® Technologies Inc. ("Theralase" or the "Company") (TSXV: TLT) (OTCQB: TLTFF),...
Program is open to two patients who completed CTD's clinical trial with Trappsol® Cyclo™ in the United States ALACHUA, FL...
OrthoIllinois Advances Highly Efficient Operating Model with HSTpathways Software SAN FRANCISCO--(BUSINESS WIRE)--lt;a href="https://twitter.com/hashtag/ASC?src=hash" target="_blank"gt;#ASClt;/agt;--HSTpathways, the leading provider of cloud-based, ambulatory...
MARLBOROUGH, Mass.--(BUSINESS WIRE)--lt;a href="https://twitter.com/hashtag/holx?src=hash" target="_blank"gt;#holxlt;/agt;--Hologic, Inc. (Nasdaq: HOLX) announced today that the Company will present at these upcoming investor conferences:...
BOSTON--(BUSINESS WIRE)--Kyn Therapeutics, a clinical-stage biotechnology company developing highly differentiated cancer immunotherapies, today announced the appointment of Jeffrey Ecsedy, Ph.D.,...
Tennessee provider seeks to make genomic information easily available at the point of care PITTSBURGH & CHICAGO--(BUSINESS WIRE)--Allscripts Healthcare Solutions,...
BRADENTON, Fla.--(BUSINESS WIRE)--lt;a href="https://twitter.com/hashtag/CardiacDeviceManagement?src=hash" target="_blank"gt;#CardiacDeviceManagementlt;/agt;--PaceMate™ and its parent company biocynetic™ are excited to announce two strategic leadership shifts as Rod...
New solution from life insurance industry leaders supports quicker and less invasive risk assessment process ST. LOUIS & BRAINTREE, Mass.--(BUSINESS...
SEATTLE--(BUSINESS WIRE)--lt;a href="https://twitter.com/hashtag/CORES?src=hash" target="_blank"gt;#CORESlt;/agt;--TransformativeMed, the leader in redefining how clinicians communicate and collaborate using EHR-embedded workflows, today announced that it...
HEIDELBERG, GERMANY / ACCESSWIRE / May 7, 2019 / Apogenix, a biopharmaceutical company developing next generation immuno-oncology therapeutics, announced today...
MARINA DEL REY, Calif., May 6, 2019 /PRNewswire/ -- PROSTATE PROS is a new monthly podcast hosted by prostate cancer...
SAN DIEGO, May 6, 2019 /PRNewswire/ -- Odin Technologies (Odin) was announced as the winner of the diagnostics startup track at...